Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension.
The immediate hemodynamic effects of a new calcium-channel blocking agent nitrendipine were studied in 12 patients with mild established essential hypertension. According to the response to mean arterial pressure, patients were classified into responders (decrease greater than 10 mm Hg, 7 patients) and nonresponders (less than or equal to 10 mm Hg, 5 patients). The decrease in arterial pressure in responders was associated with a significant (p less than 0.01) decrease in total peripheral resistance and a significant (p less than 0.05) increase in heart rate, cardiac index, and left ventricular ejection rate. The plasma norepinephrine level was significantly (p less than 0.05) increased in the responders. The response to upright tilt was qualitatively similar to pretreatment values. Thus, nitrendipine lowered arterial pressure as a result of arteriolar dilatation associated with a reflexive increase in heart rate and cardiac index. These hemodynamic properties make the drug particularly apt for use in combination with beta-adrenergic blockade for the treatment of arterial hypertension.
D000328:Adult; D001794:Blood Pressure; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002302:Cardiac Output; D005260:Female; D006339:Heart Rate; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D009568:Nitrendipine; D011187:Posture; D011725:Pyridines / Q000627:therapeutic use*; D013318:Stroke Volume
D002121:Calcium Channel Blockers; D011725:Pyridines; D009568:Nitrendipine; D009543:Nifedipine